Vanguard Group’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.9M | Buy |
|
|||||
|
2025
Q1 | $32.7M | Buy |
|
|||||
|
2024
Q4 | $42M | Buy |
|
|||||
|
2024
Q3 | $82.1M | Buy |
|
|||||
|
2024
Q2 | $83.2M | Sell |
|
|||||
|
2024
Q1 | $86.7M | Buy |
|
|||||
|
2023
Q4 | $58.1M | Buy |
|
|||||
|
2023
Q3 | $35.8M | Buy |
|
|||||
|
2023
Q2 | $38.6M | Buy |
|
|||||
|
2023
Q1 | $42.6M | Buy |
|
|||||
|
2022
Q4 | $42.3M | Buy |
|
|||||
|
2022
Q3 | $44.9M | Sell |
|
|||||
|
2022
Q2 | $61.1M | Buy |
|
|||||
|
2022
Q1 | $53.6M | Buy |
|
|||||
|
2021
Q4 | $45.8M | Buy |
|
|||||
|
2021
Q3 | $61.1M | Sell |
|
|||||
|
2021
Q2 | $68.4M | Sell |
|
|||||
|
2021
Q1 | $94.1M | Buy |
|
|||||
|
2020
Q4 | $106M | Buy |
|
|||||
|
2020
Q3 | $81.9M | Buy |
|
|||||
|
2020
Q2 | $43.5M | Buy |
|
|||||
|
2020
Q1 | $21.5M | Buy |
|
|||||
|
2019
Q4 | $29.5M | Buy |
|
|||||
|
2019
Q3 | $32.2M | Buy |
|
|||||
|
2019
Q2 | $39.6M | Buy |
|
|||||
|
2019
Q1 | $27.1M | Buy |
|
|||||
|
2018
Q4 | $21.7M | Buy |
|
|||||
|
2018
Q3 | $25.5M | Buy |
|
|||||
|
2018
Q2 | $26M | Buy |
|
|||||
|
2018
Q1 | $23.4M | Buy |
|
|||||
|
2017
Q4 | $16.6M | Buy |
|
|||||
|
2017
Q3 | $14.7M | Buy |
|
|||||
|
2017
Q2 | $4.04M | Buy |
|
|||||
|
2017
Q1 | $3.38M | Buy |
|
|||||
|
2016
Q4 | $2.21M | Buy |
|
|||||
|
2016
Q3 | $2.33M | Buy |
|
|||||
|
2016
Q2 | $797K | Hold |
|
|||||
|
2016
Q1 | $1.19M | Buy |
|
|||||
|
2015
Q4 | $1.9M | Buy |
|